RecruitingNot ApplicableNCT07450456

Effect of Virtual Reality on the Need of Premedication Before Surgery

Effect of Virtual Reality Immersion on the Need of Pharmacological Premedication Before Cardiac Surgery


Sponsor

Ente Ospedaliero Cantonale, Bellinzona

Enrollment

40 participants

Start Date

Nov 11, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study will assess, on patients requesting a pharmacological premedication in the preoperative period, if virtual reality reality could reduce the request of pharmacological premedication while maintaining a good level of comfort for the patient. The aim of this study is to understand if virtual reality could reduce the need for pharmacological premedication and their associated secondary effects.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • All patients undergoing elective surgery
  • Minimal age of 18-year-old
  • Able to give informed consent for the study
  • Requesting pharmacological premedication in the pre-operative period.

Exclusion Criteria11

  • Lacking capacity or ability to complete the consent form or to respond to the required obligations linked to the study protocol
  • Contraindications to pharmacological premedication
  • Known cognitive dysfunction, previous history of neurological/psychiatric diseases like epilepsy
  • Non Italian speaking patients
  • Injuries to the head/face that would prohibit wearing headsets
  • Infectious skin conditions of the head/face
  • Contact isolation due to bacteria and viruses
  • Symptoms of vertigo or motion sickness
  • Reduced visual or auditory acuity
  • Pregnancy
  • Claustrophobia

Interventions

DEVICEVirtual Reality

The study intervention will take place on the day of surgery, in the ward, once patient's pre-operative preparation has been completed. The virtual reality device will be started according to the choices made by the patient (scenario and music) for a 20 min session. During that time, the patient will be left at rest and the interactions with the patient will be limited as much as possible.


Locations(1)

Istituto Cardiocentro

Lugano, Canton Ticino, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07450456


Related Trials